Abstract
The American Cancer Society began a review in 1978 of all data regarding the antimitotic effect of interferons, the effect of interferons on immuno-effector cells, the activity of interferons against animal tumors, and the results of preliminary clinical trials of interferons in the United States and Europe. At the conclusion of this review, a decision was made to initiate an interferon clinical trials program. Four tumor types were chosen for the initial clinical study: lymphomas, myeloma, melanoma and breast carcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balkwill, F., Watling, D., and Taylor-Papadimitriou, J. 1978, Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast, Int. J. Cancer, 22:258.
Balkwill, F., Taylor-Papadimitriou, J., Fantes, K.H., and Sebesteny, A. 1980, Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice. Eur. J. Cancer, 16:569.
Borden, E.C., and Ball, L.A. 1981, Interferons: biochemical, cell growth inhibitory, and immunological effects, Prog. Hematol., 12:299.
Borden, E.C., Gutterman, J.U., Holland, J.F., and Dao, T.L. 1981, Interferons in breast carcinoma: design and background leading to the American Cancer Society Program, in: “The Biology of the Interferon System”, pp.391, E. DeMaeyer, G. Galasso, and H. Schellekens, eds., Elsevier/North Holland Biomedical Press, Amsterdam.
Borden, E.C., Holland, J.F., Dao, T.L., Gutterman, J.U., Wiener, L., Chang, Y-C., and Patel, J. 1982, Leukocyte-derived interferon (a) in human breast carcinoma, Ann. Int. Med., 97:1.
Came, P.E., and Moore, D.H. 1972, Effect of exogenous interferon treatment on mouse mammary tumors, J. Natl. Cancer Inst., 48:1151.
Cantell, K., Hirvonen, S., Morensen, K.E., and Phyälä, L. 1973, Human leukocyte interferon: production, purification, stability and animal experiments in the production and use of interferon for the treatment and prevention of human virus infection, in: “Proceedings of a Tissue Culture Association Workshop”, C. Waymouth, ed., In vitro Monography, 3:35.
Chirigos, M.A., and Pearson, J.W. 1973, Cure of murine leukemia with drug and interferon treatment, J. Natl. Cancer Inst., 51:1367.
Gresser, I. 1977, On the varied biologic effect of interferon, Cellular Immunol., 34:406.
Gresser, I., Maury, C., and Tovey, M. 1978, Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice, Eur. J. Cancer, 14:97.
Gutterman, J.U., Blumenschein, G.R., Alexanian, R., Yap, H-Y., Buzdar, A.U., Cabanillas, F., Hortobagyi, G.N., Hersh, E.M., Rasmussen, S.L., Harmon, M., Kramer, M., and Pestka, S. 1980, Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma, Ann. Int. Med., 93:399.
Ortaldo, J.R., and McCoy, J.L. 1980, Protective effects of interferon in mice previously exposed to lethal irradiation, Rad. Res., 81:262.
Strander, H., Adamson, V., Aparisi, T., Broström, L.A., Cantell, K., Einhorn, S., Hall, K., Ingimarsson, S., Nilsonne, U., and Söderberg, G. 1978, Adjuvant interferon treatment of osteosarcoma, Recent Results Cancer Res., 68:40.
Vilcek, J., Gresser, L., and Merigan, T. 1980, Regulatory functions of interferons, Annals NY Acad. Sei., 350:1.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Borden, E.C., Gutterman, J.U., Holland, J.F., Dao, T.L. (1983). Breast Cancer. In: Sikora, K. (eds) Interferon and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1170-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1170-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1172-0
Online ISBN: 978-1-4684-1170-6
eBook Packages: Springer Book Archive